Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors.

Vici, Patrizia; Pizzuti, Laura; Krasniqi, Eriseld; Botticelli, Andrea; Ciliberto, Gennaro; Barba, Maddalena

Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors.

Vici, Patrizia; Pizzuti, Laura; Krasniqi, Eriseld; Botticelli, Andrea; Ciliberto, Gennaro; Barba, Maddalena.

Vici P; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Pizzuti L; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Krasniqi E; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Botticelli A; Department of Clinical & Molecular Oncology, University of Rome "Sapienza", Rome, Italy.
Ciliberto G; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Barba M; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Immunotherapy ; 12(10): 675-679, 2020 07.

Article in English | MEDLINE | ID: covidwho-505589

Subject(s)

Antineoplastic Agents, Immunological/therapeutic use; Coronavirus Infections/epidemiology; Pneumonia, Viral/epidemiology; Triple Negative Breast Neoplasms/epidemiology; Triple Negative Breast Neoplasms/therapy; Antineoplastic Agents, Immunological/adverse effects; Betacoronavirus; COVID-19; Coronavirus Infections/diagnosis; Female; Humans; Immunotherapy/adverse effects; Neoplasm Metastasis; Pandemics; Pneumonia, Viral/diagnosis; Practice Guidelines as Topic; Risk; SARS-CoV-2; Triple Negative Breast Neoplasms/immunology; Triple Negative Breast Neoplasms/pathology

Keywords

Covid-19; immunotherapy; metastatic triple-negative breast cancer

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Triple Negative Breast Neoplasms / Antineoplastic Agents, Immunological Type of study: Diagnostic study / Observational study / Prognostic study Limits: Female / Humans Language: English Journal: Immunotherapy Journal subject: Allergy and Immunology / Therapeutics Year: 2020 Document Type: Article Affiliation country: Imt-2020-0142

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google